FDA PMA FDA Class 3 Approved 🇺🇸 United States

Sensor, Glucose, Invasive

PMA: P050012 · Supplement: S001 · Decision May 31, 2007
Classifications
1
FEI Numbers
23
Registration Numbers
23

Basic Information

Device Name
Sensor, Glucose, Invasive
Trade Name
SEVEN PLUS CONTINOUS GLUCOSE MONITORING SYSTEM
PMA Number
P050012
Supplement Number
S001
Device Class
FDA Class 3
Product Code
MDS
Generic Name
Sensor, glucose, invasive
Medical Specialty
Unknown
Advisory Committee
Clinical Chemistry
Decision
Approved
Decision Code
APPR
Decision Date
May 31, 2007
Date Received
June 19, 2006
Supplement Type
Panel Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N
Docket Number
07M-0255

Advisory Committee Statement

APPROVAL FOR THE STS-7 CONTINUOUS GLUCOSE MONITORING SYSTEM (STS-7 SYSTEM). THE DEVICE IS INDICATED FOR THE FOLLOWING: THE STS-7 CONTINUOUS GLUCOSE MONITORING SYSTEM (STS-7 SYSTEM) IS A GLUCOSE-MONITORING DEVICE INDICATED FOR DETECTING TRENDS AND TRACKING PATTERNS IN ADULTS (AGE 18 AND OLDER) WITH DIABETES. THE STS-7 SYSTEM IS INTENDED FOR USE BY PATIENTS AT HOME AND IN HEALTH CARE FACILITIES. THE DEVICE IS FOR PRESCRIPTION USE ONLY. THE STS-7 CONTINUOUS GLUCOSE MONITORING SYSTEM IS INDICATED FOR USE AS AN ADJUNCTIVE DEVICE TO COMPLEMENT, NOT REPLACE, INFORMATION OBTAINED FROM STANDARD HOME GLUCOSE MONITORING DEVICES. THE STS-7 CONTINUOUS GLUCOSE MONITORING SYSTEM AIDS IN THE DETECTION OF EPISODES OF HYPERGLYCEMIA AND HYPOGLYCEMIA, FACILITATING BOTH ACUTE AND LONG-TERM THERAPY ADJUSTMENTS, WHICH MAY MINIMIZE THESE EXCURSIONS. INTERPRETATION OF THE STS-7 SYSTEM RESULTS SHOULD BE BASED ON THE TRENDS AND PATTERNS SEEN WITH SEVERAL SEQUENTIAL READINGS OVER TIME.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MDS Sensor, Glucose, Invasive